Device Equals Warfarin for Stroke Prophylaxis in AF

By Crystal Phend, Senior Staff Writer, MedPage Today
Published: August 14, 2009
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner

The WATCHMAN reduced a composite endpoint of stroke, cardiovascular death, and systemic embolic events by 38% compared with warfarin (3.0 versus 4.9 events per 100 patient-years), David R. Holmes, MD, of the Mayo Clinic in Rochester, Minn., and colleagues reported in the Aug. 15 issue of The Lancet./.../